Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,204
archived clinical trials in
Healthy Studies

Fit & Active Seniors Trial
Influence of Fitness on Brain and Cognition II
Status: Enrolling
Updated:  10/18/2013
University of Illinois
mi
from
Urbana, IL
Fit & Active Seniors Trial
Influence of Fitness on Brain and Cognition II
Status: Enrolling
Updated: 10/18/2013
University of Illinois
mi
from
Urbana, IL
Click here to add this to my saved trials
Effect Of Single-Dose PF-05175157 On Metabolic And Cardiopulmonary Parameters
A Phase 1 Randomized, Double-Blind, Placebo-Controlled, Two-Way Crossover Study To Assess The Effect Of PF-05175157 As A Single Oral Dose On Metabolic And Cardiopulmonary Parameters During Steady State And Graded Exercise In Healthy Subjects
Status: Enrolling
Updated:  10/21/2013
Pfizer Investigational Site
mi
from
Boston, MA
Effect Of Single-Dose PF-05175157 On Metabolic And Cardiopulmonary Parameters
A Phase 1 Randomized, Double-Blind, Placebo-Controlled, Two-Way Crossover Study To Assess The Effect Of PF-05175157 As A Single Oral Dose On Metabolic And Cardiopulmonary Parameters During Steady State And Graded Exercise In Healthy Subjects
Status: Enrolling
Updated: 10/21/2013
Pfizer Investigational Site
mi
from
Boston, MA
Click here to add this to my saved trials
Single Dose and Multiple Dose Trial to Assess Pharmacokinetics of Obeticholic Acid (OCA)
An Open Label, Randomized, Single Dose and Multiple Dose Trial to Assess the Pharmacokinetics of Obeticholic Acid (OCA)
Status: Enrolling
Updated:  10/23/2013
Spaulding Clinical Research, LLC
mi
from
West Bend, WI
Single Dose and Multiple Dose Trial to Assess Pharmacokinetics of Obeticholic Acid (OCA)
An Open Label, Randomized, Single Dose and Multiple Dose Trial to Assess the Pharmacokinetics of Obeticholic Acid (OCA)
Status: Enrolling
Updated: 10/23/2013
Spaulding Clinical Research, LLC
mi
from
West Bend, WI
Click here to add this to my saved trials
Relative Bioavailability of 2 Fixed Dose Combinations of Empagliflozin/Metformin Compared With Single Tablets
Relative Bioavailability of Two Newly Developed FDC Tablet Strengths (25mg/1000mg and 12.5mg/750mg) of Empagliflozin/Metformin Extended Release Compared With the Free Combination of Empagliflozin and Metformin Extended Release in Healthy Subjects (an Open-label, Randomised, Single Dose, Two-way Crossover Study)
Status: Enrolling
Updated:  10/29/2013
Boehringer Ingelheim Investigational Site
mi
from
Austin, TX
Relative Bioavailability of 2 Fixed Dose Combinations of Empagliflozin/Metformin Compared With Single Tablets
Relative Bioavailability of Two Newly Developed FDC Tablet Strengths (25mg/1000mg and 12.5mg/750mg) of Empagliflozin/Metformin Extended Release Compared With the Free Combination of Empagliflozin and Metformin Extended Release in Healthy Subjects (an Open-label, Randomised, Single Dose, Two-way Crossover Study)
Status: Enrolling
Updated: 10/29/2013
Boehringer Ingelheim Investigational Site
mi
from
Austin, TX
Click here to add this to my saved trials
A Study of the Effect of BIIB023 on Muscle Atrophy in Healthy Male Volunteers
A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Effect of Intravenous BIIB023 (Anti-TWEAK) on Lower Limb Muscle Mass and Strength During and After Knee-Joint Immobilization in Healthy Male Volunteers
Status: Enrolling
Updated:  11/1/2013
Clinical Research Facility
mi
from
Evansville, IN
A Study of the Effect of BIIB023 on Muscle Atrophy in Healthy Male Volunteers
A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Effect of Intravenous BIIB023 (Anti-TWEAK) on Lower Limb Muscle Mass and Strength During and After Knee-Joint Immobilization in Healthy Male Volunteers
Status: Enrolling
Updated: 11/1/2013
Clinical Research Facility
mi
from
Evansville, IN
Click here to add this to my saved trials
Polymorphic Effects of Cytochrome P450 3A5 on Pharmacokinetics of Maraviroc and Its Metabolites
Polymorphic Effects of Cytochrome P450 3A5 on Pharmacokinetics of Maraviroc and Its Metabolites
Status: Enrolling
Updated:  11/4/2013
The Johns Hopkins University School of Medicine Division of Clinical Pharmacology
mi
from
Baltimore, MD
Polymorphic Effects of Cytochrome P450 3A5 on Pharmacokinetics of Maraviroc and Its Metabolites
Polymorphic Effects of Cytochrome P450 3A5 on Pharmacokinetics of Maraviroc and Its Metabolites
Status: Enrolling
Updated: 11/4/2013
The Johns Hopkins University School of Medicine Division of Clinical Pharmacology
mi
from
Baltimore, MD
Click here to add this to my saved trials
Phase I Study Evaluating the Safety and Pharmacokinetics of Budesonide, Glycopyrronium, and Formoterol Fumarate Inhalation Aerosol (BGF MDI) in Healthy Volunteers
A Phase I, Randomized, Double-Blind Within Device, Single-Dose, Four-Period, Six-Treatment, Cross-Over Study Evaluating the Safety and Pharmacokinetics of Three Doses of Budesonide, Glycopyrronium, and Formoterol Fumarate Inhalation Aerosol (BGF MDI), One Dose of Glycopyrronium and Formoterol Fumarate Inhalation Aerosol (GFF MDI), and Two Doses of Symbicort® Inhalation Aerosol in Healthy Volunteers
Status: Enrolling
Updated:  11/4/2013
Pearl Therapeutics Study Site
mi
from
Baltimore, MD
Phase I Study Evaluating the Safety and Pharmacokinetics of Budesonide, Glycopyrronium, and Formoterol Fumarate Inhalation Aerosol (BGF MDI) in Healthy Volunteers
A Phase I, Randomized, Double-Blind Within Device, Single-Dose, Four-Period, Six-Treatment, Cross-Over Study Evaluating the Safety and Pharmacokinetics of Three Doses of Budesonide, Glycopyrronium, and Formoterol Fumarate Inhalation Aerosol (BGF MDI), One Dose of Glycopyrronium and Formoterol Fumarate Inhalation Aerosol (GFF MDI), and Two Doses of Symbicort® Inhalation Aerosol in Healthy Volunteers
Status: Enrolling
Updated: 11/4/2013
Pearl Therapeutics Study Site
mi
from
Baltimore, MD
Click here to add this to my saved trials
Next-Day Residual Effects of Gabapentin, Diphenhydramine and Triazolam on Simulated Driving Performance in Normal Volunteers
A Phase 3 Randomized, Double-blind, Cross-over, Placebo-controlled, Multi-center, Single-dose, Clinical Trial to Assess the Next-Day Residual Effects of Gabapentin, Diphenhydramine and Triazolam on Simulated Driving Performance in Normal Volunteers
Status: Enrolling
Updated:  11/5/2013
Miami Research Associates
mi
from
South Miami, FL
Next-Day Residual Effects of Gabapentin, Diphenhydramine and Triazolam on Simulated Driving Performance in Normal Volunteers
A Phase 3 Randomized, Double-blind, Cross-over, Placebo-controlled, Multi-center, Single-dose, Clinical Trial to Assess the Next-Day Residual Effects of Gabapentin, Diphenhydramine and Triazolam on Simulated Driving Performance in Normal Volunteers
Status: Enrolling
Updated: 11/5/2013
Miami Research Associates
mi
from
South Miami, FL
Click here to add this to my saved trials
Next-Day Residual Effects of Gabapentin, Diphenhydramine and Triazolam on Simulated Driving Performance in Normal Volunteers
A Phase 3 Randomized, Double-blind, Cross-over, Placebo-controlled, Multi-center, Single-dose, Clinical Trial to Assess the Next-Day Residual Effects of Gabapentin, Diphenhydramine and Triazolam on Simulated Driving Performance in Normal Volunteers
Status: Enrolling
Updated:  11/5/2013
Baptist Sleep Centers, LLP
mi
from
South Miami, FL
Next-Day Residual Effects of Gabapentin, Diphenhydramine and Triazolam on Simulated Driving Performance in Normal Volunteers
A Phase 3 Randomized, Double-blind, Cross-over, Placebo-controlled, Multi-center, Single-dose, Clinical Trial to Assess the Next-Day Residual Effects of Gabapentin, Diphenhydramine and Triazolam on Simulated Driving Performance in Normal Volunteers
Status: Enrolling
Updated: 11/5/2013
Baptist Sleep Centers, LLP
mi
from
South Miami, FL
Click here to add this to my saved trials
Next-Day Residual Effects of Gabapentin, Diphenhydramine and Triazolam on Simulated Driving Performance in Normal Volunteers
A Phase 3 Randomized, Double-blind, Cross-over, Placebo-controlled, Multi-center, Single-dose, Clinical Trial to Assess the Next-Day Residual Effects of Gabapentin, Diphenhydramine and Triazolam on Simulated Driving Performance in Normal Volunteers
Status: Enrolling
Updated:  11/5/2013
Neurotrials Research, Inc.
mi
from
Atlanta, GA
Next-Day Residual Effects of Gabapentin, Diphenhydramine and Triazolam on Simulated Driving Performance in Normal Volunteers
A Phase 3 Randomized, Double-blind, Cross-over, Placebo-controlled, Multi-center, Single-dose, Clinical Trial to Assess the Next-Day Residual Effects of Gabapentin, Diphenhydramine and Triazolam on Simulated Driving Performance in Normal Volunteers
Status: Enrolling
Updated: 11/5/2013
Neurotrials Research, Inc.
mi
from
Atlanta, GA
Click here to add this to my saved trials
Next-Day Residual Effects of Gabapentin, Diphenhydramine and Triazolam on Simulated Driving Performance in Normal Volunteers
A Phase 3 Randomized, Double-blind, Cross-over, Placebo-controlled, Multi-center, Single-dose, Clinical Trial to Assess the Next-Day Residual Effects of Gabapentin, Diphenhydramine and Triazolam on Simulated Driving Performance in Normal Volunteers
Status: Enrolling
Updated:  11/5/2013
NeuroTrials Research Sleep Lab
mi
from
Atlanta, GA
Next-Day Residual Effects of Gabapentin, Diphenhydramine and Triazolam on Simulated Driving Performance in Normal Volunteers
A Phase 3 Randomized, Double-blind, Cross-over, Placebo-controlled, Multi-center, Single-dose, Clinical Trial to Assess the Next-Day Residual Effects of Gabapentin, Diphenhydramine and Triazolam on Simulated Driving Performance in Normal Volunteers
Status: Enrolling
Updated: 11/5/2013
NeuroTrials Research Sleep Lab
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study to Evaluate the Effect of IV Doses of Gmi-1070 on Qtc Intervals in Healthy African-American Adult Subjects
A Phase 1, Randomized, 3-way, Crossover Single Dose, Placebo, and Active Controlled Study to Evaluate the Effect of Intravenous Doses of Gmi-1070 on Qtc Intervals in Healthy African-American Adult Subjects
Status: Enrolling
Updated:  11/5/2013
Pfizer Investigational Site
mi
from
Bridgeport, CT
A Study to Evaluate the Effect of IV Doses of Gmi-1070 on Qtc Intervals in Healthy African-American Adult Subjects
A Phase 1, Randomized, 3-way, Crossover Single Dose, Placebo, and Active Controlled Study to Evaluate the Effect of Intravenous Doses of Gmi-1070 on Qtc Intervals in Healthy African-American Adult Subjects
Status: Enrolling
Updated: 11/5/2013
Pfizer Investigational Site
mi
from
Bridgeport, CT
Click here to add this to my saved trials
Compare the Same Dosage of Insulin Using a Combination of Cartridges, 30 Units as 2 Cartridges vs. 1 Cartridge
A Phase 1, Open-label, Randomized, Crossover Clinical Trial in Healthy Normal Volunteers to Evaluate the Bioequivalence of 30 U TI Inhalation Powder Delivered by Gen2 Inhaler Using One 30 U Cartridge Versus a Combination of 10 U and 20 U Cartridges
Status: Enrolling
Updated:  11/6/2013
Clinical Research Facility
mi
from
Newark, NJ
Compare the Same Dosage of Insulin Using a Combination of Cartridges, 30 Units as 2 Cartridges vs. 1 Cartridge
A Phase 1, Open-label, Randomized, Crossover Clinical Trial in Healthy Normal Volunteers to Evaluate the Bioequivalence of 30 U TI Inhalation Powder Delivered by Gen2 Inhaler Using One 30 U Cartridge Versus a Combination of 10 U and 20 U Cartridges
Status: Enrolling
Updated: 11/6/2013
Clinical Research Facility
mi
from
Newark, NJ
Click here to add this to my saved trials
Antacid Interaction Study
A Phase 1, Randomized, Open-Label, Drug-Drug Interaction Study to Evaluate the Potential Pharmacokinetic and Pharmacodynamic Interaction Between Lesinurad and Calcium Carbonate and Aluminum/Magnesium Hydroxide-Containing Antacids in Healthy Adult Male Subjects
Status: Enrolling
Updated:  11/8/2013
Clinical Research Facility
mi
from
Kalamazoo, MI
Antacid Interaction Study
A Phase 1, Randomized, Open-Label, Drug-Drug Interaction Study to Evaluate the Potential Pharmacokinetic and Pharmacodynamic Interaction Between Lesinurad and Calcium Carbonate and Aluminum/Magnesium Hydroxide-Containing Antacids in Healthy Adult Male Subjects
Status: Enrolling
Updated: 11/8/2013
Clinical Research Facility
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
A Phase I Study to Assess Cardiac and General Safety and Pharmacokinetics of 60 mg MGN1703
A Phase I, Placebo-Controlled, Double-Blind, 2-Period Crossover Study to Assess Cardiac and General Safety and Pharmacokinetics of a Single Subcutaneous Dose of 60 mg MGN1703 in Healthy Volunteers
Status: Enrolling
Updated:  11/12/2013
Spaulding Clinical
mi
from
West Bend, WI
A Phase I Study to Assess Cardiac and General Safety and Pharmacokinetics of 60 mg MGN1703
A Phase I, Placebo-Controlled, Double-Blind, 2-Period Crossover Study to Assess Cardiac and General Safety and Pharmacokinetics of a Single Subcutaneous Dose of 60 mg MGN1703 in Healthy Volunteers
Status: Enrolling
Updated: 11/12/2013
Spaulding Clinical
mi
from
West Bend, WI
Click here to add this to my saved trials
Lesinurad Tablet Relative Bioavailability
A Phase 1, Randomized, Open-Label, Crossover Study in Healthy Adult Male Subjects to Assess the Relative Bioavailability of Lesinurad Tablets Manufactured at Two Different Sites
Status: Enrolling
Updated:  11/12/2013
Clinical Research Facility
mi
from
Glendale, CA
Lesinurad Tablet Relative Bioavailability
A Phase 1, Randomized, Open-Label, Crossover Study in Healthy Adult Male Subjects to Assess the Relative Bioavailability of Lesinurad Tablets Manufactured at Two Different Sites
Status: Enrolling
Updated: 11/12/2013
Clinical Research Facility
mi
from
Glendale, CA
Click here to add this to my saved trials
A Pharmacokinetics Study Comparing PF-06438179 and Infliximab in Healthy Volunteers (REFLECTIONS B537-01)
Phase 1, Double Blind, Randomized, Parallel-Group, Single-Dose, 3-Arm, Comparative Pharmacokinetic Study of PF-06438179 and Infliximab Sourced From US and EU Administered to Healthy Volunteers
Status: Enrolling
Updated:  11/14/2013
Pfizer Investigational Site
mi
from
Overland Park, KA
A Pharmacokinetics Study Comparing PF-06438179 and Infliximab in Healthy Volunteers (REFLECTIONS B537-01)
Phase 1, Double Blind, Randomized, Parallel-Group, Single-Dose, 3-Arm, Comparative Pharmacokinetic Study of PF-06438179 and Infliximab Sourced From US and EU Administered to Healthy Volunteers
Status: Enrolling
Updated: 11/14/2013
Pfizer Investigational Site
mi
from
Overland Park, KA
Click here to add this to my saved trials
Gene Polymorphism Study of Normal Individual Inflammasome Genes
Immunological Characterization of Blood and Inflammasome Gene Segment Polymorphism Analysis of Normal Healthy Individuals
Status: Enrolling
Updated:  11/14/2013
Davis Heart and Lung Research Institute
mi
from
Columbus, OH
Gene Polymorphism Study of Normal Individual Inflammasome Genes
Immunological Characterization of Blood and Inflammasome Gene Segment Polymorphism Analysis of Normal Healthy Individuals
Status: Enrolling
Updated: 11/14/2013
Davis Heart and Lung Research Institute
mi
from
Columbus, OH
Click here to add this to my saved trials
A Study of LY2801653 in Healthy Participants
Disposition of [^14C]-LY2801653 Following Oral Administration in Healthy Subjects
Status: Enrolling
Updated:  11/15/2013
Clinical Research Facility
mi
from
Madison, WI
A Study of LY2801653 in Healthy Participants
Disposition of [^14C]-LY2801653 Following Oral Administration in Healthy Subjects
Status: Enrolling
Updated: 11/15/2013
Clinical Research Facility
mi
from
Madison, WI
Click here to add this to my saved trials
A Pharmacokinetic Study in Healthy Participants to Assess the Pharmacokinetics and Safety of a Supratherapeutic Dose of PCI-32765 (Ibrutinib) Capsule and Solution Formulations Administered With Food
Open-Label, 2-Period, Sequential Design, Exploratory Pharmacokinetic Study In Healthy Subjects to Assess the Pharmacokinetics and Safety of a Supra-Therapeutic Dose of Ibrutinib Capsule and Solution Formulations Administered With Food
Status: Enrolling
Updated:  11/18/2013
Clinical Research Facility
mi
from
Newark, NJ
A Pharmacokinetic Study in Healthy Participants to Assess the Pharmacokinetics and Safety of a Supratherapeutic Dose of PCI-32765 (Ibrutinib) Capsule and Solution Formulations Administered With Food
Open-Label, 2-Period, Sequential Design, Exploratory Pharmacokinetic Study In Healthy Subjects to Assess the Pharmacokinetics and Safety of a Supra-Therapeutic Dose of Ibrutinib Capsule and Solution Formulations Administered With Food
Status: Enrolling
Updated: 11/18/2013
Clinical Research Facility
mi
from
Newark, NJ
Click here to add this to my saved trials
Effect of SSP-004184 (SPD602) on the Pharmacokinetics of Simvastatin in Healthy Adult Subjects
A Phase 1, Randomized, Open-label, Cross-over Study to Evaluate the Pharmacokinetic Interaction Between SSP-004184 (SPD602) and Simvastatin in Healthy Adult Subjects
Status: Enrolling
Updated:  11/18/2013
Clinical Pharmacology of Miami
mi
from
Miami, FL
Effect of SSP-004184 (SPD602) on the Pharmacokinetics of Simvastatin in Healthy Adult Subjects
A Phase 1, Randomized, Open-label, Cross-over Study to Evaluate the Pharmacokinetic Interaction Between SSP-004184 (SPD602) and Simvastatin in Healthy Adult Subjects
Status: Enrolling
Updated: 11/18/2013
Clinical Pharmacology of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
The Effect of 3 Probiotic Strains on Bile Acids, Satiety, and Inflammation
Evaluation of the Effect of 3 Probiotic Strains on Bile Acids, Satiety, and Inflammation in Healthy, Middle-aged Adults: a Randomized, Double-blinded, Placebo-controlled Study
Status: Enrolling
Updated:  11/19/2013
University of Florida
mi
from
Gainesville, FL
The Effect of 3 Probiotic Strains on Bile Acids, Satiety, and Inflammation
Evaluation of the Effect of 3 Probiotic Strains on Bile Acids, Satiety, and Inflammation in Healthy, Middle-aged Adults: a Randomized, Double-blinded, Placebo-controlled Study
Status: Enrolling
Updated: 11/19/2013
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
A Study of LY2157299 in Healthy Participants
Effect of Food on the Pharmacokinetics of LY2157299 Monohydrate in Healthy Subjects
Status: Enrolling
Updated:  11/21/2013
Clinical Research Facility
mi
from
Miami, FL
A Study of LY2157299 in Healthy Participants
Effect of Food on the Pharmacokinetics of LY2157299 Monohydrate in Healthy Subjects
Status: Enrolling
Updated: 11/21/2013
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Investigation of Intraocular Pressure (IOP) Reduction Efficacy of Travoprost Ophthalmic Solution in Patients With Normal Tension Glaucoma
Investigation of IOP Reduction Efficacy of Travoprost Ophthalmic Solution in Patients With Normal Tension Glaucoma
Status: Enrolling
Updated:  11/21/2013
Alcon Call Center
mi
from
Fort Worth, TX
Investigation of Intraocular Pressure (IOP) Reduction Efficacy of Travoprost Ophthalmic Solution in Patients With Normal Tension Glaucoma
Investigation of IOP Reduction Efficacy of Travoprost Ophthalmic Solution in Patients With Normal Tension Glaucoma
Status: Enrolling
Updated: 11/21/2013
Alcon Call Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Feasibility Clinical Study of NLA Tool-US
Evaluate the Feasibility of the NLA Tool, a Combined Assessment of Nutritional and Physical Functional Status, to Provide Personalized Advice for the Independence and Mobility of Elderly
Status: Enrolling
Updated:  11/21/2013
Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University
mi
from
Boston, MA
Feasibility Clinical Study of NLA Tool-US
Evaluate the Feasibility of the NLA Tool, a Combined Assessment of Nutritional and Physical Functional Status, to Provide Personalized Advice for the Independence and Mobility of Elderly
Status: Enrolling
Updated: 11/21/2013
Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University
mi
from
Boston, MA
Click here to add this to my saved trials
Pharmacokinetic Interaction Between SSP-004184 (SPD602) and Midazolam in Healthy Adult Subjects
A Phase 1, Randomized, Open Label, Crossover Study to Evaluate the Pharmacokinetic Interaction Between SSP-004184 (SPD602) and Midazolam in Healthy Adult Subjects
Status: Enrolling
Updated:  11/26/2013
Clinical Pharmacology of Miami
mi
from
Miami, FL
Pharmacokinetic Interaction Between SSP-004184 (SPD602) and Midazolam in Healthy Adult Subjects
A Phase 1, Randomized, Open Label, Crossover Study to Evaluate the Pharmacokinetic Interaction Between SSP-004184 (SPD602) and Midazolam in Healthy Adult Subjects
Status: Enrolling
Updated: 11/26/2013
Clinical Pharmacology of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
A Study To Assess The Safety Of PF-06342674 In Healthy Volunteers
A Phase 1 Study To Evaluate The Safety, Tolerability, Immunogenicity, Pharmacokinetics And Pharmacodynamics Of Escalating Doses Of Pf-06342674 (RN168) In Healthy Volunteers
Status: Enrolling
Updated:  12/2/2013
Pfizer Investigational Site
mi
from
New Haven, CT
A Study To Assess The Safety Of PF-06342674 In Healthy Volunteers
A Phase 1 Study To Evaluate The Safety, Tolerability, Immunogenicity, Pharmacokinetics And Pharmacodynamics Of Escalating Doses Of Pf-06342674 (RN168) In Healthy Volunteers
Status: Enrolling
Updated: 12/2/2013
Pfizer Investigational Site
mi
from
New Haven, CT
Click here to add this to my saved trials
Almonds: Digestive Health and Immune Function of Adults and Children
Almonds: Digestive Health and Immune Function of Adults and Children
Status: Enrolling
Updated:  12/2/2013
University of Florida
mi
from
Gainesville, FL
Almonds: Digestive Health and Immune Function of Adults and Children
Almonds: Digestive Health and Immune Function of Adults and Children
Status: Enrolling
Updated: 12/2/2013
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Phase I Dose Escalaion Study of 9cUAB30
A Randomized, Double Blind Phase I Dose Escalation Study of the Novel Retinoid 9cUAB30
Status: Enrolling
Updated:  12/2/2013
University of Wisconsin
mi
from
Madison, WI
Phase I Dose Escalaion Study of 9cUAB30
A Randomized, Double Blind Phase I Dose Escalation Study of the Novel Retinoid 9cUAB30
Status: Enrolling
Updated: 12/2/2013
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
A Two-part Multiple Dose Study to Assess the Safety and Effects of AZD3293 in Healthy Elderly and Alzheimer's Patients
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Two-Part, Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Effect on Biomarkers of AZD3293 in Plasma and Cerebrospinal Fluid in Healthy Male and Non-Fertile Female Elderly Volunteers and in Mild-to-Moderate Alzheimer Disease Patients
Status: Enrolling
Updated:  12/4/2013
Clinical Research Facility
mi
from
Glendale, CA
A Two-part Multiple Dose Study to Assess the Safety and Effects of AZD3293 in Healthy Elderly and Alzheimer's Patients
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Two-Part, Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Effect on Biomarkers of AZD3293 in Plasma and Cerebrospinal Fluid in Healthy Male and Non-Fertile Female Elderly Volunteers and in Mild-to-Moderate Alzheimer Disease Patients
Status: Enrolling
Updated: 12/4/2013
Clinical Research Facility
mi
from
Glendale, CA
Click here to add this to my saved trials
A Two-part Multiple Dose Study to Assess the Safety and Effects of AZD3293 in Healthy Elderly and Alzheimer's Patients
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Two-Part, Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Effect on Biomarkers of AZD3293 in Plasma and Cerebrospinal Fluid in Healthy Male and Non-Fertile Female Elderly Volunteers and in Mild-to-Moderate Alzheimer Disease Patients
Status: Enrolling
Updated:  12/4/2013
Clinical Research Facility
mi
from
Glendale, CA
A Two-part Multiple Dose Study to Assess the Safety and Effects of AZD3293 in Healthy Elderly and Alzheimer's Patients
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Two-Part, Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Effect on Biomarkers of AZD3293 in Plasma and Cerebrospinal Fluid in Healthy Male and Non-Fertile Female Elderly Volunteers and in Mild-to-Moderate Alzheimer Disease Patients
Status: Enrolling
Updated: 12/4/2013
Clinical Research Facility
mi
from
Glendale, CA
Click here to add this to my saved trials
A Phase I Trial to Investigate the Safety and Tolerability of PF-06412562
A Phase 1, Double Blind, Sponsor Open, Randomized, Placebo Controlled, Crossover Dose Escalation Study With Open And Double Blind (Sponsor Open), Cohorts To Investigate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of PF-06412562 In Healthy Subjects
Status: Enrolling
Updated:  12/4/2013
Pfizer Investigational Site
mi
from
New Haven, CT
A Phase I Trial to Investigate the Safety and Tolerability of PF-06412562
A Phase 1, Double Blind, Sponsor Open, Randomized, Placebo Controlled, Crossover Dose Escalation Study With Open And Double Blind (Sponsor Open), Cohorts To Investigate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of PF-06412562 In Healthy Subjects
Status: Enrolling
Updated: 12/4/2013
Pfizer Investigational Site
mi
from
New Haven, CT
Click here to add this to my saved trials
OCT Reference Database
Topcon 3D OCT-1 Maestro and 3D OCT-2000 Optical Coherence Tomography Systems: Reference Database Study
Status: Enrolling
Updated:  12/10/2013
Horizon Eye Specialist & Laser Center
mi
from
Scottsdale, AZ
OCT Reference Database
Topcon 3D OCT-1 Maestro and 3D OCT-2000 Optical Coherence Tomography Systems: Reference Database Study
Status: Enrolling
Updated: 12/10/2013
Horizon Eye Specialist & Laser Center
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
OCT Reference Database
Topcon 3D OCT-1 Maestro and 3D OCT-2000 Optical Coherence Tomography Systems: Reference Database Study
Status: Enrolling
Updated:  12/10/2013
Valley Eyecare Center
mi
from
Livermore, CA
OCT Reference Database
Topcon 3D OCT-1 Maestro and 3D OCT-2000 Optical Coherence Tomography Systems: Reference Database Study
Status: Enrolling
Updated: 12/10/2013
Valley Eyecare Center
mi
from
Livermore, CA
Click here to add this to my saved trials
OCT Reference Database
Topcon 3D OCT-1 Maestro and 3D OCT-2000 Optical Coherence Tomography Systems: Reference Database Study
Status: Enrolling
Updated:  12/10/2013
Keck School of Medicine
mi
from
Los Angeles, CA
OCT Reference Database
Topcon 3D OCT-1 Maestro and 3D OCT-2000 Optical Coherence Tomography Systems: Reference Database Study
Status: Enrolling
Updated: 12/10/2013
Keck School of Medicine
mi
from
Los Angeles, CA
Click here to add this to my saved trials
OCT Reference Database
Topcon 3D OCT-1 Maestro and 3D OCT-2000 Optical Coherence Tomography Systems: Reference Database Study
Status: Enrolling
Updated:  12/10/2013
Western University of Health Sciences
mi
from
Pomona, CA
OCT Reference Database
Topcon 3D OCT-1 Maestro and 3D OCT-2000 Optical Coherence Tomography Systems: Reference Database Study
Status: Enrolling
Updated: 12/10/2013
Western University of Health Sciences
mi
from
Pomona, CA
Click here to add this to my saved trials
OCT Reference Database
Topcon 3D OCT-1 Maestro and 3D OCT-2000 Optical Coherence Tomography Systems: Reference Database Study
Status: Enrolling
Updated:  12/10/2013
Stat University of New York College of Optometry
mi
from
New York, NY
OCT Reference Database
Topcon 3D OCT-1 Maestro and 3D OCT-2000 Optical Coherence Tomography Systems: Reference Database Study
Status: Enrolling
Updated: 12/10/2013
Stat University of New York College of Optometry
mi
from
New York, NY
Click here to add this to my saved trials
Comparison of 30 Units of TI (Technosphere® Insulin) Prepared With Insulin From Two Different Suppliers
A Phase 1, Open-label, Randomized, Crossover Clinical Trial to Evaluate PK/PD of 30 U TI Inhalation Powders Prepared With Insulin From Two Different Suppliers
Status: Enrolling
Updated:  12/13/2013
Clinical Research Facility
mi
from
Chula Vista, CA
Comparison of 30 Units of TI (Technosphere® Insulin) Prepared With Insulin From Two Different Suppliers
A Phase 1, Open-label, Randomized, Crossover Clinical Trial to Evaluate PK/PD of 30 U TI Inhalation Powders Prepared With Insulin From Two Different Suppliers
Status: Enrolling
Updated: 12/13/2013
Clinical Research Facility
mi
from
Chula Vista, CA
Click here to add this to my saved trials
A Study To Establish The Equivalence Of 2 Palbociclib (PD-0332991) Formulations To The Intended Final Market Product
A Phase 1, Open-Label 3 Sequence 3 Period Crossover Study Of Palbociclib (PD-0332991) In Healthy Volunteers To Establish The Bioequivalence Of The Phase 1/2 And Phase 3 Formulation To Palbociclib ICH Formulation Under Fasted Conditions
Status: Enrolling
Updated:  12/16/2013
Pfizer Investigational Site
mi
from
Overland Park, KA
A Study To Establish The Equivalence Of 2 Palbociclib (PD-0332991) Formulations To The Intended Final Market Product
A Phase 1, Open-Label 3 Sequence 3 Period Crossover Study Of Palbociclib (PD-0332991) In Healthy Volunteers To Establish The Bioequivalence Of The Phase 1/2 And Phase 3 Formulation To Palbociclib ICH Formulation Under Fasted Conditions
Status: Enrolling
Updated: 12/16/2013
Pfizer Investigational Site
mi
from
Overland Park, KA
Click here to add this to my saved trials
A Study To Investigate The Drug-Drug Interaction Potential Of Rifampin OnThe Investigational Agent Palbociclib (PD-0332991)
A Phase 1, Open-Label Fixed-Sequence 2-Period Study To Investigate The Effect Of Multiple Doses Of Rifampin On Palbociclib (PD-0332991) Pharmacokinetics In Healthy Volunteers
Status: Enrolling
Updated:  12/16/2013
Pfizer Investigational Site
mi
from
New Haven, CT
A Study To Investigate The Drug-Drug Interaction Potential Of Rifampin OnThe Investigational Agent Palbociclib (PD-0332991)
A Phase 1, Open-Label Fixed-Sequence 2-Period Study To Investigate The Effect Of Multiple Doses Of Rifampin On Palbociclib (PD-0332991) Pharmacokinetics In Healthy Volunteers
Status: Enrolling
Updated: 12/16/2013
Pfizer Investigational Site
mi
from
New Haven, CT
Click here to add this to my saved trials
SMART: Somatotrophics, Memory, and Aging Research Trial
GHRH: Cognition in Aging and MCI
Status: Enrolling
Updated:  12/17/2013
Univ of Washington
mi
from
Seattle, WA
SMART: Somatotrophics, Memory, and Aging Research Trial
GHRH: Cognition in Aging and MCI
Status: Enrolling
Updated: 12/17/2013
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
A Phase 1 Study To Evaluate The Safety And Tolerability Of PF-06252616 In Healthy Subjects
A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of PF-06252616 In Healthy Subjects
Status: Enrolling
Updated:  1/2/2014
Pfizer Investigational Site
mi
from
New Haven, CT
A Phase 1 Study To Evaluate The Safety And Tolerability Of PF-06252616 In Healthy Subjects
A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of PF-06252616 In Healthy Subjects
Status: Enrolling
Updated: 1/2/2014
Pfizer Investigational Site
mi
from
New Haven, CT
Click here to add this to my saved trials
A Phase I Trial to Investigate the Safety and Tolerability of PF-06649751
A Phase 1, Double Blind, Sponsor Open, Randomized, Placebo Controlled, Crossover, Single Oral Dose Escalation Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-06649751 in Healthy Subjects
Status: Enrolling
Updated:  1/2/2014
Pfizer Investigational Site
mi
from
New Haven, CT
A Phase I Trial to Investigate the Safety and Tolerability of PF-06649751
A Phase 1, Double Blind, Sponsor Open, Randomized, Placebo Controlled, Crossover, Single Oral Dose Escalation Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-06649751 in Healthy Subjects
Status: Enrolling
Updated: 1/2/2014
Pfizer Investigational Site
mi
from
New Haven, CT
Click here to add this to my saved trials
A Study to Assess the Pharmacokinetics of Intranasally Administered Esketamine in Healthy Japanese and Caucasian Volunteers
An Open-label, Single-Dose Study to Assess the Pharmacokinetics, Safety and Tolerability of Intranasally Administered Esketamine in Healthy Japanese and Caucasian Subjects
Status: Enrolling
Updated:  1/3/2014
Clinical Research Facility
mi
from
Cypress, CA
A Study to Assess the Pharmacokinetics of Intranasally Administered Esketamine in Healthy Japanese and Caucasian Volunteers
An Open-label, Single-Dose Study to Assess the Pharmacokinetics, Safety and Tolerability of Intranasally Administered Esketamine in Healthy Japanese and Caucasian Subjects
Status: Enrolling
Updated: 1/3/2014
Clinical Research Facility
mi
from
Cypress, CA
Click here to add this to my saved trials
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK2336805 Alone and With the Co-administration of TMC435 in Healthy Japanese Participants.
A Phase 1, Double-blind, Placebo-controlled, Randomized, Single Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of GSK2336805 (Part 1), Followed by an Open-label, Randomized, 4-way Crossover Study to Evaluate Short-term Safety, Tolerability and Pharmacokinetics of the Co-administration of TMC435 and GSK2336805 at Steady-state (Part 2), in Healthy Japanese Subjects
Status: Enrolling
Updated:  1/8/2014
Clinical Research Facility
mi
from
Cypress, CA
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK2336805 Alone and With the Co-administration of TMC435 in Healthy Japanese Participants.
A Phase 1, Double-blind, Placebo-controlled, Randomized, Single Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of GSK2336805 (Part 1), Followed by an Open-label, Randomized, 4-way Crossover Study to Evaluate Short-term Safety, Tolerability and Pharmacokinetics of the Co-administration of TMC435 and GSK2336805 at Steady-state (Part 2), in Healthy Japanese Subjects
Status: Enrolling
Updated: 1/8/2014
Clinical Research Facility
mi
from
Cypress, CA
Click here to add this to my saved trials
A Study Evaluating The Safety Of PF-05280014 And Trastuzumab In Healthy Male Volunteers (REFLECTIONS B327-06)
Phase 1, Double-Blind, Randomized, Parallel-Group, Single-Dose, 2-Arm, Safety Study Of PF-05280014 And Trastuzumab Sourced From The US Administered To Healthy Male Volunteers
Status: Enrolling
Updated:  1/10/2014
Pfizer Investigational Site
mi
from
Overland Park, KA
A Study Evaluating The Safety Of PF-05280014 And Trastuzumab In Healthy Male Volunteers (REFLECTIONS B327-06)
Phase 1, Double-Blind, Randomized, Parallel-Group, Single-Dose, 2-Arm, Safety Study Of PF-05280014 And Trastuzumab Sourced From The US Administered To Healthy Male Volunteers
Status: Enrolling
Updated: 1/10/2014
Pfizer Investigational Site
mi
from
Overland Park, KA
Click here to add this to my saved trials
A Study Evaluating The Safety Of PF-05280014 And Trastuzumab In Healthy Male Volunteers (REFLECTIONS B327-06)
Phase 1, Double-Blind, Randomized, Parallel-Group, Single-Dose, 2-Arm, Safety Study Of PF-05280014 And Trastuzumab Sourced From The US Administered To Healthy Male Volunteers
Status: Enrolling
Updated:  1/10/2014
Pfizer Investigational Site
mi
from
Overland Park, KA
A Study Evaluating The Safety Of PF-05280014 And Trastuzumab In Healthy Male Volunteers (REFLECTIONS B327-06)
Phase 1, Double-Blind, Randomized, Parallel-Group, Single-Dose, 2-Arm, Safety Study Of PF-05280014 And Trastuzumab Sourced From The US Administered To Healthy Male Volunteers
Status: Enrolling
Updated: 1/10/2014
Pfizer Investigational Site
mi
from
Overland Park, KA
Click here to add this to my saved trials
A Study To Examine The Distribution Of PF-05212377 In The Brain Of Healthy Volunteer Subjects Using Positron Emission Tomography And A Radioactive Tracer Following Oral Administration Of One Dose Of PF-05212377
A Phase 1, Open-Label Study To Evaluate 5-HT2a Receptor Occupancy As Measured By Positron Emission Tomography (PET) With Ligand [11C]MDL100907 Following Single Oral Dose Administration Of PP-05212377 (SAM-760) In Healthy Subjects
Status: Enrolling
Updated:  1/13/2014
Pfizer Investigational Site
mi
from
New Haven, CT
A Study To Examine The Distribution Of PF-05212377 In The Brain Of Healthy Volunteer Subjects Using Positron Emission Tomography And A Radioactive Tracer Following Oral Administration Of One Dose Of PF-05212377
A Phase 1, Open-Label Study To Evaluate 5-HT2a Receptor Occupancy As Measured By Positron Emission Tomography (PET) With Ligand [11C]MDL100907 Following Single Oral Dose Administration Of PP-05212377 (SAM-760) In Healthy Subjects
Status: Enrolling
Updated: 1/13/2014
Pfizer Investigational Site
mi
from
New Haven, CT
Click here to add this to my saved trials
A Study To Examine The Distribution Of PF-05212377 In The Brain Of Healthy Volunteer Subjects Using Positron Emission Tomography And A Radioactive Tracer Following Oral Administration Of One Dose Of PF-05212377
A Phase 1, Open-Label Study To Evaluate 5-HT2a Receptor Occupancy As Measured By Positron Emission Tomography (PET) With Ligand [11C]MDL100907 Following Single Oral Dose Administration Of PP-05212377 (SAM-760) In Healthy Subjects
Status: Enrolling
Updated:  1/13/2014
Pfizer Investigational Site
mi
from
New Haven, CT
A Study To Examine The Distribution Of PF-05212377 In The Brain Of Healthy Volunteer Subjects Using Positron Emission Tomography And A Radioactive Tracer Following Oral Administration Of One Dose Of PF-05212377
A Phase 1, Open-Label Study To Evaluate 5-HT2a Receptor Occupancy As Measured By Positron Emission Tomography (PET) With Ligand [11C]MDL100907 Following Single Oral Dose Administration Of PP-05212377 (SAM-760) In Healthy Subjects
Status: Enrolling
Updated: 1/13/2014
Pfizer Investigational Site
mi
from
New Haven, CT
Click here to add this to my saved trials
A Study To Examine The Distribution Of PF-05212377 In The Brain Of Healthy Volunteer Subjects Using Positron Emission Tomography And A Radioactive Tracer Following Oral Administration Of One Dose Of PF-05212377
A Phase 1, Open-Label Study To Evaluate 5-HT2a Receptor Occupancy As Measured By Positron Emission Tomography (PET) With Ligand [11C]MDL100907 Following Single Oral Dose Administration Of PP-05212377 (SAM-760) In Healthy Subjects
Status: Enrolling
Updated:  1/13/2014
Pfizer Investigational Site
mi
from
New Haven, CT
A Study To Examine The Distribution Of PF-05212377 In The Brain Of Healthy Volunteer Subjects Using Positron Emission Tomography And A Radioactive Tracer Following Oral Administration Of One Dose Of PF-05212377
A Phase 1, Open-Label Study To Evaluate 5-HT2a Receptor Occupancy As Measured By Positron Emission Tomography (PET) With Ligand [11C]MDL100907 Following Single Oral Dose Administration Of PP-05212377 (SAM-760) In Healthy Subjects
Status: Enrolling
Updated: 1/13/2014
Pfizer Investigational Site
mi
from
New Haven, CT
Click here to add this to my saved trials